The chickenpox vaccine provides long-lasting protection, but no one can say it lasts a guaranteed number of years. The CDC states directly that it is not known exactly how long a vaccinated person is protected. What we do know is that the longest studies tracking vaccinated children show protection holding strong at 90% effectiveness after 14 years, with no clear sign of fading during that window.
What the Research Actually Shows
The most informative long-term study followed vaccinated children for 14 years and found vaccine effectiveness remained at roughly 90% through the end of the study period, with no indication of waning over time. That’s encouraging, but the study also came with a realistic projection: as the immune memory naturally weakens beyond that window, effectiveness could dip below 70% within the following four to five years. So protection likely remains strong for at least 10 to 15 years, and possibly much longer, but it probably isn’t permanent for everyone.
Because the chickenpox vaccine is a live vaccine (meaning it contains a weakened form of the actual virus), it tends to train the immune system more thoroughly than some other vaccine types. Live vaccines in general are known for producing durable, long-lasting immunity. This is one reason researchers are cautiously optimistic that protection extends well beyond the 14-year mark for most people, even if the exact ceiling remains unclear.
Why Two Doses Matter
The current schedule calls for two doses: the first between 12 and 15 months of age, and the second between ages 4 and 6. This two-dose schedule wasn’t always the standard. When the vaccine was first introduced in the United States in 1995, only one dose was recommended. Outbreaks among vaccinated children made it clear that a single dose, while helpful, left gaps in protection. The second dose was added to the schedule in 2006.
A single dose prevents roughly 80 to 85% of all chickenpox cases and over 95% of severe cases. Two doses push overall effectiveness above 90%. The second dose also appears to shore up long-term durability, reducing the chances of “breakthrough” infections, which are mild cases of chickenpox that occur in vaccinated people. Breakthrough cases typically involve fewer than 50 blisters, little to no fever, and resolve quickly. They’re a nuisance, not a danger, but the second dose makes even those less likely.
Can You Still Get Chickenpox After Vaccination?
Yes, but it’s uncommon and almost always mild. Breakthrough chickenpox happens in a small percentage of fully vaccinated people, usually after exposure to someone with an active infection. The rash tends to be mostly flat red spots rather than the fluid-filled blisters typical of full-blown chickenpox, and it clears faster. People who experience breakthrough infections are also less contagious than unvaccinated people with chickenpox.
The more important point is that severe chickenpox, the kind that sends people to the hospital with complications like pneumonia, skin infections, or brain inflammation, is extraordinarily rare in vaccinated individuals. Even if vaccine-induced immunity weakens somewhat over time, the immune system retains enough memory to mount a rapid response and prevent serious illness.
Do Adults Need a Booster?
There is currently no recommendation for a chickenpox vaccine booster in adults who completed the two-dose series as children. The CDC’s immunization schedules do not include a routine adult booster for varicella. This could change as the generation that received the vaccine in childhood ages into their 30s and 40s and more long-term data becomes available, but for now, two doses are considered sufficient.
Adults who never had chickenpox and were never vaccinated are a different story. If you’re in that group, two doses spaced at least 28 days apart are recommended. Chickenpox is significantly more dangerous in adults than in children, with higher rates of hospitalization and complications, so getting vaccinated as an adult is worth the effort.
If you’re unsure whether you were vaccinated or had chickenpox as a child, a blood test can check for antibodies to the varicella virus. If antibodies are present, you’re considered immune regardless of how that immunity was acquired.
Chickenpox Vaccine and Shingles
The chickenpox virus never fully leaves the body after infection. It hides in nerve tissue and can reactivate decades later as shingles. This happens in people who had natural chickenpox, but it can also happen, at a much lower rate, in people who were vaccinated. The weakened virus used in the vaccine can establish the same kind of dormant presence, though it reactivates far less frequently than the wild virus.
The shingles vaccine is a separate product recommended for adults 50 and older (or younger adults with weakened immune systems). It is not a booster for the childhood chickenpox vaccine. The two vaccines use different technologies and target different stages of the virus’s behavior. Getting the chickenpox vaccine as a child does not eliminate the need for a shingles vaccine later in life, though your overall risk of shingles may already be lower than someone who had natural chickenpox.